newsfilter
← Latest News
GlobeNewswire·

Satsuma Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

SOUTH SAN FRANCISCO, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA), a clinical-stage biopharmaceutical company developing STS101 (dihydroergotamine (DHE) nasal powder), a novel investigational therapeutic produc